$1.43
-0.12-7.74%
À la fermeture: -
$1.43
0.0001000.01%
Après les heures de négociation: 6:01 PM EDT
Comments
Loading...
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Ironwood Pharmaceuticals. Restez informé des achats, des ventes et de l'impact sur le marché des actions Ironwood Pharmaceuticals.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Ironwood Pharmaceuticals Inc Insiders ?
Les initiés n’ont signalé aucun achat/vente au cours des 30 derniers jours.
Achats et ventes récents notables d’initiés
- Le août 13, 2025 Gregory Martini, le CHIEF FINANCIAL OFFICER sold 1.26K actions pour $0.84 chacune.
- Le août 13, 2025 Tammi Gaskins, le CHIEF COMMERCIAL OFFICER sold 1.32K actions pour $0.84 chacune.
- Le août 13, 2025 Ronald Silver, le PRINCIPAL ACCOUNTING OFFICER sold 2.85K actions pour $0.84 chacune.
Statistiques de propriété pour Ironwood Pharmaceuticals Inc
Actions en circulation
162.434M
Actions détenues par les initiés
12.008M
Pourcentage d'actions détenu par les initiés
7.39%
Actions détenues par les institutions
51.891M
Pourcentage d'actions détenu par les institutions
31.9%
Aug 13, 2025 | CHIEF COMMERCIAL OFFICER | -1.32K | $0.84 | -$1.11K | SELL | -0.54% | 241.28K | Aug 11 | ||
Aug 13, 2025 | CHIEF LEGAL OFFICER | -7.75K | $0.84 | -$6.51K | SELL | -1.90% | 400.38K | Aug 11 | ||
Aug 13, 2025 | CHIEF FINANCIAL OFFICER | -1.26K | $0.84 | -$1.06K | SELL | -0.69% | 182.54K | Aug 11 | ||
Aug 13, 2025 | PRINCIPAL ACCOUNTING OFFICER | -2.85K | $0.84 | -$2.39K | SELL | -1.02% | 276.81K | Aug 11 | ||
May 20, 2025 | CHIEF EXECUTIVE OFFICER | 526.65K | $0.58 | -$7.74K | GRANT | 45.38% | 1.69M | May 16 - May 20 | ||
May 20, 2025 | CHIEF COMMERCIAL OFFICER | -2.56K | $0.58 | -$1.49K | SELL | -1.05% | 242.60K | May 16 | ||
Feb 12, 2025 | CHIEF EXECUTIVE OFFICER | -139.06K | $1.76 | -$244.75K | SELL | -10.70% | 1.16M | Feb 10 | ||
Feb 12, 2025 | PRINCIPAL ACCOUNTING OFFICER | -12.05K | $1.76 | -$21.20K | SELL | -4.13% | 279.65K | Feb 10 | ||
Feb 12, 2025 | SVP, CMO, HEAD-RES&DRUG | 92.06K | $1.76 | -$72.63K | GRANT | 19.93% | 554.01K | Feb 10 | ||
Feb 12, 2025 | CHIEF LEGAL OFFICER | 83.28K | $1.76 | -$68.53K | GRANT | 25.64% | 408.13K | Feb 10 | ||
Feb 12, 2025 | CHIEF FINANCIAL OFFICER | -12.05K | $1.76 | -$21.21K | SELL | -6.15% | 183.81K | Feb 10 | ||
Nov 20, 2024 | SVP, CHIEF BUSINESS OFFICER | -5.36K | $4.08 | -$21.87K | SELL | -1.85% | 284.69K | Nov 18 | ||
Nov 20, 2024 | SVP, COO AND CFO | -11.00K | $4.08 | -$44.88K | SELL | -3.43% | 309.57K | Nov 18 | ||
Aug 14, 2024 | CHIEF LEGAL OFFICER | -9.91K | $4.27 | -$42.32K | SELL | -3.36% | 284.66K | Aug 12 | ||
Aug 14, 2024 | PRINCIPAL ACCOUNTING OFFICER | -3.11K | $4.27 | -$13.27K | SELL | -1.92% | 158.37K | Aug 12 | ||
Jun 12, 2024 | — | -22.77K | $6.29 | -$143.20K | SELL | -14.03% | 139.53K | Jun 10 | ||
Jun 10, 2024 | — | -80.00K | $6.47 | -$517.69K | SELL | -62.19% | 48.63K | Jun 06 - Jun 07 | ||
May 22, 2024 | CHIEF EXECUTIVE OFFICER | -67.62K | $6.45 | -$436.14K | SELL | -5.55% | 1.15M | May 20 | ||
May 22, 2024 | SVP, CHIEF BUSINESS OFFICER | -22.73K | $6.45 | -$146.58K | SELL | -7.31% | 288.03K | May 20 | ||
May 22, 2024 | CMO,SVP,HEAD-RES&DRUG | -16.13K | $6.45 | -$104.03K | SELL | -3.75% | 413.72K | May 20 | ||
May 22, 2024 | CHIEF LEGAL OFFICER | -17.40K | $6.45 | -$112.26K | SELL | -5.58% | 294.57K | May 20 | ||
Mar 08, 2024 | — | 6.92K | $8.70 | $60.20K | BUY | 6.06% | 121.03K | Mar 06 | ||
Mar 06, 2024 | SVP, CHIEF FINANCIAL OFFICER | 10.68K | $9.38 | $100.22K | BUY | 3.67% | 301.73K | Mar 04 | ||
Feb 14, 2024 | CHIEF LEGAL OFFICER | 7.05K | $15.24 | -$722.07K | GRANT | 2.59% | 279.22K | Feb 12 | ||
Feb 14, 2024 | CMO,SVP,HEAD-RES&DRUG | 15.81K | $15.24 | -$588.54K | GRANT | 4.17% | 394.91K | Feb 12 | ||
Feb 14, 2024 | PRINCIPAL ACCOUNTING OFFICER | 19.30K | $15.24 | -$120.52K | GRANT | 13.58% | 161.48K | Feb 12 | ||
Feb 14, 2024 | SVP, CHIEF BUSINESS OFFICER | 55.47K | $15.24 | -$150.05K | GRANT | 25.42% | 273.64K | Feb 12 | ||
Feb 14, 2024 | CHIEF EXECUTIVE OFFICER | -177.16K | $15.24 | -$2.70M | SELL | -17.54% | 832.77K | Feb 12 | ||
Dec 18, 2023 | DIRECTOR | -9.93K | $11.19 | -$111.07K | SELL | -9.32% | 96.57K | Dec 14 | ||
Nov 22, 2023 | SVP, CHIEF BUSINESS OFFICER | -3.29K | $9.69 | -$31.85K | SELL | -1.49% | 217.37K | Nov 20 | ||
Sep 18, 2023 | SVP, CHIEF FINANCIAL OFFICER | 36.07K | $8.32 | $300.12K | BUY | 23.63% | 188.73K | Sep 15 | ||
Aug 16, 2023 | PRINCIPAL ACCOUNTING OFFICER | -1.98K | $10.04 | -$19.84K | SELL | -1.45% | 134.17K | Aug 14 | ||
Aug 16, 2023 | CHIEF LEGAL OFFICER | -7.04K | $10.04 | -$70.73K | SELL | -3.54% | 192.19K | Aug 14 | ||
Jun 01, 2023 | CHIEF EXECUTIVE OFFICER | -26.63K | $10.70 | -$284.96K | SELL | -3.39% | 758.28K | May 30 | ||
May 24, 2023 | CMO,SVP,HEAD-RES&DRUG | -10.32K | $10.12 | -$104.48K | SELL | -3.11% | 321.13K | May 22 | ||
May 24, 2023 | SVP, CHIEF BUSINESS OFFICER | -6.30K | $10.12 | -$63.81K | SELL | -2.79% | 219.33K | May 22 | ||
May 24, 2023 | CHIEF EXECUTIVE OFFICER | -36.00K | $10.12 | -$364.32K | SELL | -4.39% | 784.92K | May 22 | ||
May 10, 2023 | CHIEF EXECUTIVE OFFICER | -21.15K | $10.62 | -$224.59K | SELL | -2.51% | 820.92K | May 08 | ||
Mar 29, 2023 | CHIEF EXECUTIVE OFFICER | -46.13K | $10.67 | -$492.20K | SELL | -5.19% | 842.06K | Mar 27 | ||
Mar 07, 2023 | CHIEF EXECUTIVE OFFICER | -33.76K | $11.22 | -$378.74K | SELL | -4.95% | 647.60K | Mar 03 | ||
Mar 01, 2023 | PRINCIPAL ACCOUNTING OFFICER | -5.98K | $11.36 | -$67.90K | SELL | -5.72% | 98.49K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | SVP, CHIEF OPERATING OFFICER | -34.17K | $11.36 | -$388.19K | SELL | -9.32% | 332.65K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | CHIEF EXECUTIVE OFFICER | -61.23K | $11.36 | -$695.52K | SELL | -8.25% | 681.35K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | CMO,SVP,HEAD-RES&DRUG | -19.32K | $11.36 | -$219.48K | SELL | -6.88% | 261.59K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | CHIEF LEGAL OFFICER | -6.70K | $11.36 | -$76.07K | SELL | -4.77% | 133.74K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | SVP, CHIEF BUSINESS OFFICER | -3.57K | $11.36 | -$40.59K | SELL | -2.31% | 151.40K | Feb 27 - Feb 28 | ||
Jan 09, 2023 | CHIEF EXECUTIVE OFFICER | 0.00 | $11.86 | -$46.60K | SELL-OPTIONS | 0.00% | 712.44K | Jan 05 | ||
Dec 16, 2022 | SVP, CHIEF OPERATING OFFICER | -27.00K | $12.39 | -$334.53K | SELL | -7.19% | 348.74K | Dec 14 | ||
Nov 23, 2022 | SVP, CHIEF FINANCIAL OFFICER | -6.58K | $11.56 | -$76.04K | SELL | -7.74% | 78.42K | Nov 21 | ||
Nov 23, 2022 | PRINCIPAL ACCOUNTING OFFICER | -682.00 | $11.56 | -$7.88K | SELL | -0.65% | 104.47K | Nov 21 | ||
Nov 23, 2022 | SVP, CHIEF BUSINESS OFFICER | -3.33K | $11.56 | -$38.55K | SELL | -2.12% | 154.21K | Nov 21 | ||
Oct 05, 2022 | CHIEF EXECUTIVE OFFICER | -18.90K | $10.41 | -$196.74K | SELL | -2.58% | 712.44K | Oct 03 | ||
Sep 06, 2022 | CHIEF EXECUTIVE OFFICER | -26.45K | $10.65 | -$281.65K | SELL | -3.49% | 731.34K | Sep 01 | ||
Aug 17, 2022 | PRINCIPAL ACCOUNTING OFFICER | -2.01K | $11.77 | -$23.70K | SELL | -1.88% | 105.15K | Aug 15 | ||
Aug 17, 2022 | SVP, CHIEF OPERATING OFFICER | -994.00 | $11.77 | -$11.70K | SELL | -0.26% | 375.74K | Aug 15 | ||
Aug 17, 2022 | CHIEF LEGAL OFFICER | -7.33K | $11.77 | -$86.27K | SELL | -4.96% | 140.44K | Aug 15 | ||
Aug 15, 2022 | DIRECTOR | -70.00K | $11.78 | -$824.60K | SELL | -11.83% | 521.76K | Aug 11 | ||
Aug 10, 2022 | SVP, CHIEF OPERATING OFFICER | -29.44K | $11.66 | -$344.26K | SELL | -7.25% | 376.73K | Aug 08 - Aug 09 | ||
Aug 03, 2022 | CHIEF EXECUTIVE OFFICER | -23.23K | $11.35 | -$263.65K | SELL | -2.97% | 757.78K | Aug 01 | ||
Jul 05, 2022 | CHIEF EXECUTIVE OFFICER | -19.96K | $11.58 | -$231.13K | SELL | -2.50% | 778.92K | Jun 30 | ||
Jun 16, 2022 | DIRECTOR | -7.61K | $11.65 | -$88.66K | SELL | -8.29% | 84.15K | Jun 14 | ||
Jun 09, 2022 | DIRECTOR | 0.00 | $11.83 | -$68.54K | SELL-OPTIONS | 0.00% | 591.76K | Jun 07 | ||
May 25, 2022 | CHIEF EXECUTIVE OFFICER | -36.31K | $11.50 | -$417.54K | SELL | -4.35% | 798.88K | May 23 | ||
May 25, 2022 | PRINCIPAL ACCOUNTING OFFICER | -120.00 | $11.50 | -$1.38K | SELL | -0.11% | 105.07K | May 23 | ||
May 25, 2022 | CMO,SVP,HEAD-RES&DRUG | -10.58K | $11.50 | -$121.70K | SELL | -3.82% | 266.25K | May 23 | ||
May 25, 2022 | SVP, CHIEF OPERATING OFFICER | -13.54K | $11.50 | -$155.68K | SELL | -3.24% | 404.07K | May 23 | ||
Mar 25, 2022 | PRINCIPAL ACCOUNTING OFFICER | -3.03K | $12.75 | -$38.65K | SELL | -2.80% | 105.19K | Mar 24 | ||
Mar 16, 2022 | DIRECTOR | -20.00K | $11.67 | -$233.40K | SELL | -14.45% | 118.37K | Mar 14 | ||
Mar 02, 2022 | PRINCIPAL ACCOUNTING OFFICER | -2.24K | $10.77 | -$24.10K | SELL | -3.53% | 61.21K | Feb 28 | ||
Mar 02, 2022 | CHIEF EXECUTIVE OFFICER | -48.42K | $10.77 | -$521.53K | SELL | -7.63% | 586.32K | Feb 28 | ||
Mar 02, 2022 | CMO,SVP,HEAD-RES&DRUG | -17.61K | $10.77 | -$189.63K | SELL | -8.27% | 195.38K | Feb 28 | ||
Mar 02, 2022 | SVP, CHIEF OPERATING OFFICER | -28.96K | $10.77 | -$311.92K | SELL | -8.13% | 327.11K | Feb 28 | ||
Dec 23, 2021 | CHIEF EXECUTIVE OFFICER | -46.33K | $11.41 | -$528.59K | SELL | -7.46% | 574.45K | Dec 22 | ||
Dec 20, 2021 | SVP, CHIEF OPERATING OFFICER | -27.00K | $11.28 | -$304.56K | SELL | -7.78% | 319.90K | Dec 16 | ||
Dec 16, 2021 | DIRECTOR | -10.00K | $11.02 | -$110.20K | SELL | -6.74% | 138.37K | Dec 14 | ||
Nov 24, 2021 | CHIEF EXECUTIVE OFFICER | -52.64K | $11.58 | -$609.62K | SELL | -7.84% | 618.54K | Nov 23 | ||
Nov 24, 2021 | SVP, CHIEF OPERATING OFFICER | -17.19K | $11.58 | -$199.09K | SELL | -4.75% | 344.67K | Nov 23 | ||
Nov 24, 2021 | CMO,SVP,HEAD-RES&DRUG | -13.78K | $11.58 | -$159.53K | SELL | -6.98% | 183.66K | Nov 23 | ||
Nov 24, 2021 | PRINCIPAL ACCOUNTING OFFICER | -1.46K | $11.58 | -$16.93K | SELL | -2.33% | 61.21K | Nov 23 | ||
Aug 18, 2021 | PRINCIPAL ACCOUNTING OFFICER | -567.00 | $13.48 | -$7.64K | SELL | -0.90% | 62.67K | Aug 16 | ||
Aug 18, 2021 | SVP, CHIEF OPERATING OFFICER | -680.00 | $13.48 | -$9.17K | SELL | -0.19% | 361.86K | Aug 16 | ||
Jun 16, 2021 | DIRECTOR | -23.57K | $11.59 | -$273.19K | SELL | -3.97% | 570.19K | Jun 14 | ||
May 26, 2021 | CMO, SVP & HEAD DRUG DEVT. | -2.08K | $12.25 | -$25.44K | SELL | -1.04% | 197.44K | May 24 | ||
May 26, 2021 | SVP, CHIEF OPERATING OFFICER | -516.00 | $12.25 | -$6.32K | SELL | -0.14% | 362.54K | May 24 | ||
May 26, 2021 | PRESIDENT AND INTERIM CEO | -1.72K | $12.25 | -$21.02K | SELL | -0.30% | 566.50K | May 24 | ||
Mar 10, 2021 | DIRECTOR | 225.00K | $10.38 | $2.34M | BUY | 1.39% | 16.43M | Mar 08 - Mar 10 | ||
Mar 05, 2021 | DIRECTOR | 775.00K | $10.01 | $7.76M | BUY | 5.02% | 16.20M | Mar 03 - Mar 05 | ||
Mar 02, 2021 | DIRECTOR | 1.35M | $9.44 | $12.74M | BUY | 9.59% | 15.43M | Feb 26 - Mar 02 | ||
Mar 02, 2021 | CMO, SVP & HEAD DRUG DEVT. | -4.44K | $9.11 | -$40.44K | SELL | -2.69% | 160.86K | Feb 26 | ||
Mar 02, 2021 | SVP, CHIEF OPERATING OFFICER | -13.65K | $9.11 | -$124.36K | SELL | -4.26% | 306.68K | Feb 26 | ||
Mar 02, 2021 | DIRECTOR | 3.00K | $8.90 | $26.70K | BUY | 1.17% | 258.95K | Feb 26 | ||
Mar 02, 2021 | PRESIDENT | -14.69K | $9.11 | -$133.78K | SELL | -3.02% | 471.58K | Feb 26 | ||
Mar 02, 2021 | CHIEF EXECUTIVE OFFICER | -30.68K | $9.11 | -$279.45K | SELL | -6.12% | 470.61K | Feb 26 | ||
Mar 02, 2021 | SVP, GC & SECRETARY | -6.99K | $9.11 | -$63.67K | SELL | -5.40% | 122.34K | Feb 26 | ||
Mar 02, 2021 | SVP, CFO & TREASURER | -18.41K | $9.11 | -$167.68K | SELL | -5.19% | 336.24K | Feb 26 | ||
Feb 26, 2021 | DIRECTOR | 12.00K | $9.20 | $110.37K | BUY | 4.92% | 255.95K | Feb 24 - Feb 25 | ||
Dec 08, 2020 | — | 0.00 | $10.81 | -$19.06K | OPTION EXERCISE | 0.00% | 93.04K | Dec 04 | ||
Nov 13, 2020 | — | 0.00 | $10.53 | -$8.69K | OPTION EXERCISE | 0.00% | 93.04K | Nov 11 | ||
Nov 10, 2020 | — | -394.00 | $10.92 | -$4.30K | SELL | -0.17% | 235.38K | Nov 09 | ||
Nov 10, 2020 | — | -2.80K | $11.14 | -$31.16K | SELL | -2.92% | 93.04K | Nov 06 - Nov 09 | ||
Nov 10, 2020 | — | -836.00 | $10.92 | -$9.13K | SELL | -0.64% | 128.83K | Nov 09 | ||
Nov 10, 2020 | — | -1.42K | $10.92 | -$15.45K | SELL | -0.52% | 269.70K | Nov 09 |
FAQ
Est-ce que le trading d'initiés est légal ?
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Quels sont quelques exemples de manipulation de marché ?
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.